Jeremy Grantham Astrazeneca PLC Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $997,612 - $1.14 Million	-28,700 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $17,275 - $18,525	-500 Reduced 1.71%	28,700 $1.01 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $125,286 - $139,194	-3,800 Reduced 11.52%	29,200 $1.02 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $455,678 - $493,876	14,200 Added 75.53%	33,000 $1.15 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $544,448 - $639,200	18,800	18,800 $637,000

1,360

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $210B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.